The proposal would eliminate health-plan-run PBMs in Medicaid and establish a single state-contracted PBM, a move supporters ...
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The $2.6 billion provider of specialty insurance and reinsurance, based in Maryland Heights, said it is realigning ...
Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...
Researchers rush to preserve federal health databases before they disappear from government websites
Journalists have long relied on federal health data for their reporting. We include several tips that they can use to help ...
Known as the middlemen of the pharma industry, PBMs play an intermediary role between health insurers, pharmacies and patients, negotiating drug prices and designing formulary plans while mediating ...
The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback